Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Lung Cancer

Free Subscription Articles published in Eur J Cancer Retrieve available abstracts of 35 articles: HTML format Text format

Single Articles

January 2012
1. CHEN J , Qi Y, Wampfler JA, Jatoi A, et al
   Effect of cigarette smoking on quality of life in small cell lung cancer patients.
   Eur J Cancer. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. KAWAGUCHI T , Takada M, Ando M, Okishio K, et al
   A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. O'BRIEN ME , Myerson JS, Coward JI, Puglisi M, et al
   A phase II study of (18)F-fluorodeoxyglucose PET-CT in non-small cell lung cancer patients receiving erlotinib (Tarceva(R)); objective and symptomatic responses at 6 and 12weeks.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. PESCE GA , Klingbiel D, Ribi K, Zouhair A, et al
   Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinica
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. BECKER A , Crombag L, Heideman DA, Thunnissen FB, et al
   Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment.
   Eur J Cancer. 2011;47:2603-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
6. LEARY AF , Castro DG, Nicholson AG, Ashley S, et al
   Establishing an EGFR mutation screening service for non-small cell lung cancer - Sample quality criteria and candidate histological predictors.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. GAAFAR RM , Surmont VF, Scagliotti GV, Van Klaveren RJ, et al
   A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03).
   Eur J Cancer. 2011;47:2331-40.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
8. LAL R , Enting D, Kristeleit H
   Systemic treatment of non-small-cell lung cancer.
   Eur J Cancer. 2011;47 Suppl 3:S375-7.
   PubMed     Text format     Related articles   
   
   
   
   
9. O'CONNOR SJ
   Review of the incidence, prevalence, mortality and causative factors for lung cancer in Europe.
   Eur J Cancer. 2011;47 Suppl 3:S346-7.
   PubMed     Text format     Related articles   
   
   
   
   
10. KRISTELEIT H , Enting D, Lai R
    Basic science of lung cancer.
    Eur J Cancer. 2011;47 Suppl 3:S319-21.
    PubMed     Text format     Related articles   
    
    
    
    
11. LE CHEVALIER T
    Management of early-stage non-small-cell lung cancer (NSCLC).
    Eur J Cancer. 2011;47 Suppl 3:S292-3.
    PubMed     Text format     Related articles   
    
    
    
    
12. PLANCHARD D , Le Pechoux C
    Small cell lung cancer: new clinical recommendations and current status of biomarker assessment.
    Eur J Cancer. 2011;47 Suppl 3:S272-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. DE MARINIS F , Ricciardi S
    Second-line treatment options in advanced non-small cell lung cancer.
    Eur J Cancer. 2011;47 Suppl 3:S258-71.
    PubMed     Text format     Related articles   
    
    
    
    
14. GRIDELLI C , Rossi A, Maione P
    2010 Consensus on Lung Cancer, new clinical recommendations and current status of biomarker assessment - First-line therapy.
    Eur J Cancer. 2011;47 Suppl 3:S248-57.
    PubMed     Text format     Related articles   
    
    
    
    
15. VAN KLAVEREN RJ
    Lung cancer screening.
    Eur J Cancer. 2011;47 Suppl 3:S147-55.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
16. RIAZ SP , Luchtenborg M, Jack RH, Coupland VH, et al
    Variation in surgical resection for lung cancer in relation to survival: Population-based study in England 2004-2006.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. PARK CY , Son JY, Jin CH, Nam JS, et al
    EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. BAIRD AM , Gray SG, O'Byrne KJ
    IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF.
    Eur J Cancer. 2011;47:1908-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
19. WANDERS R , Steevens J, Botterweck A, Dingemans AM, et al
    Treatment with curative intent of stage III non-small cell lung cancer patients of 75years: A prospective population-based study.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. HOLGERSSON G , Bergstrom S, Bergqvist M, Nyman J, et al
    Swedish Lung Cancer Radiation Study Group: Predictive value of histology for radiotherapy response in patients with non-small cell lung cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SU L , Liu G, Hao X, Zhong N, et al
    Death Receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
22. CALDERONE R , Nimako K, Leary A, Popat S, et al
    Under usage of zoledronic acid in non-small cell lung cancer patients with metastatic bone disease - a short communication.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. O'BRIEN ME , Konopa K, Lorigan P, Bosquee L, et al
    Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. FENG Y , Hu J, Ma J, Feng K, et al
    RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
25. NIE Q , Yang XN, An SJ, Zhang XC, et al
    CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. KOCH A , Bergman B, Holmberg E, Sederholm C, et al
    Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
27. BELVEDERE O , Follador A, Rossetto C, Merlo V, et al
    A randomised phase II study of docetaxel/oxaliplatin and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe-Adria Thoracic Oncology Multidisciplinary group trial (ATOM 019).
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
28. MURATA Y , Hirose T, Yamaoka T, Shirai T, et al
    Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small-cell lung cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
29. ZHAN P , Suo LJ, Qian Q, Shen XK, et al
    Chlamydia pneumoniae infection and lung cancer risk: A meta-analysis.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
30. MERIKALLIO H , Kaarteenaho R, Paakko P, Lehtonen S, et al
    Impact of smoking on the expression of claudins in lung carcinoma.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
31. DE PETRIS L , Branden E, Herrmann R, Sanchez BC, et al
    Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer.
    Eur J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. MENVIELLE G , Soerjomataram I, de Vries E, Engholm G, et al
    Scenarios of future lung cancer incidence by educational level: Modelling study in Denmark.
    Eur J Cancer. 2010;46:2625-2632.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. SOERJOMATARAM I , de Vries E, Engholm G, Paludan-Muller G, et al
    Impact of a smoking and alcohol intervention programme on lung and breast cancer incidence in Denmark: An example of dynamic modelling with Prevent.
    Eur J Cancer. 2010;46:2617-2624.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. KELLEHER FC , McDermott R
    The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
    Eur J Cancer. 2010;46:2357-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
35. VILMAR A , Santoni-Rugiu E, Sorensen JB
    ERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial.
    Eur J Cancer. 2010;46:1554-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: